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Abstract
Background: Detectable lead levels in children’s blood have been associated with
increased cognitive difficulties, attention deficits, and poorer academic performance.
Children enrolled in Medicaid have higher rates of elevated blood lead levels, yet
requirements to test all children at age 1 and 2 who are enrolled in Medicaid are not being
met. Nationally, 34% of children enrolled in Medicaid do not undergo proper blood lead
level screening. The aim of this project was to increase required blood lead level
screening rates for children with Medicaid insurance at a private pediatric practice in the
Shenandoah Valley in Virginia.
Methods: The Institute for Healthcare Improvement (IHI) Model for Improvement was
used to guide this practice improvement. This model stresses the importance of
performing a needs assessment, establishing a baseline, and tracking balancing measures
to ensure the intervention has no unintended consequences. A baseline rate of screening
was collected by retrospective chart review, a physical review of the clinic was
performed, and staff interviews were conducted. The Plan, Do, Study, Act (PDSA) cycle
was the used to implement the intervention. Run charts were displayed weekly to show
progress.
Intervention: Three cycles of the interventions were run. The first intervention was an
inservice to update staff to the current guidelines. Second, an official policy change was
enacted, and finally an electronic health record (EHR) flag was employed as a reminder.
Results: The initial assessment revealed that blood lead screenings were not being
conducted on 2-year-old children enrolled in Medicaid. Interventions to change the
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practice and screen 2-year-old children enrolled in Medicaid were designed based on a
search of the literature.
The IHI Model for Improvement produced statistically significant improvement
(p<0.001) in screening rates of 2-year-old children enrolled in Medicaid. The run charts
further illustrated improvement with each intervention.
This project was undertaken in partial fulfillment of the Doctorate of Nursing Practice.
Key words: Lead, Screening, Quality, Pediatric
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INCREASING LEAD SCREENING
Background
Screening for elevated blood lead levels is an important component of the wellchild check-up. It is the task of primary care providers to capture children at risk of an
elevated blood lead level with the use of screening protocols. Lead is a neuro-toxin, and
children with even very low levels of lead in their blood are known to have cognitive
impairment, and can show signs of developmental delay, subtle behavioral problems,
distractibility, hyperactivity and delayed sexual development. There are also links to
increased dental caries in children with mildly elevated blood lead levels (CDC, 2014).
Children in lower socio-economic groups and African American children are at a higher
risk of being identified with elevated blood lead levels than their white, higher economic
class counterparts (Jones et al., 2009).
There have been significant advances in preventing elevated blood lead levels in
children. In the early 1970’s the United States began a campaign to lower environmental

lead exposure. In 1971 the Lead-Based Paint Poisoning Prevention Act was initiated, and
lead based gasoline began to be phased out in 1973 (American Academy of Pediatrics
[AAP], 2016). By 1988 residential leaded paint and plumbing were banned, and lead in
gasoline was eliminated (AAP, 2016). These primary prevention efforts have been
effective, yet the problem of elevated blood lead levels persists, and children in the
United States continue to function as the canary in the mine for detection of lead
exposure.
Average blood lead levels have declined steadily over the past 4 decades, yet
there are still children with detectable lead in their bloodstreams. It is estimated that 24
million housing units in the United States have lead hazards related to the use of lead-
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based paint and pipe solder. Chipped or peeling paint is a significant risk factor for
elevated blood lead levels, particularly in the toddler with their developmentally
appropriate hand to mouth behavior. Many families are not aware of their lead exposure,
or simply cannot afford to live in modern, or safely refurbished homes (Knighton, Payne
& Speedie, 2016).
In 2005 the AAP adopted recommendations by the Centers for Disease Control
and Prevention (CDC) to consider a blood lead level above 10 ug/dL a “level of concern”
(AAP, 2016). In 2012, the CDC determined that children with very low levels of blood
lead may still experience problems, and there is no safe level of blood lead (Raymond,
Wheeler & Brown, 2014). Thus, the level of concern was lowered to 5 ug/dL, or the
97.5th percentile of all blood lead levels found in children that year (AAP, 2016). This
new lowered level will have significant impact on screening efforts as it has the potential
to increase the number of children with problematic blood lead levels. Leafe, Irigoyen,
DeLago, Hassan and Braitman (2015) found that in a high-risk urban area, problematic
lead levels increased 9-fold with the new lowered blood lead level threshold.
Virginia is not federally funded for lead reporting, making population estimates of
screening rates in Virginia impossible. It is difficult to assess where lead elimination
efforts should be focused when screening efforts are not robust. The Virginia
Department of Health (2016) guidelines state that all children enrolled in Medicaid are
required to be tested at both 1 and 2 years-of-age.
Blood lead screenings are necessary to identify children with detectable blood
lead levels. Until screening rates are robust, it is difficult to determine where to focus
primary prevention efforts. Flint, Michigan provides an example of the importance of
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blood lead screening. A diligent pediatrician noted elevations in blood lead levels during
routine screenings, which led to the discovery of lead in the public water system. A
change in water source increased the percentage of children with elevated blood lead
levels from 2.4% to 4.9% (Hanna-Attisha, LaChance, Sadler, & Champney Schnepp,
2016).
Problem
Jones et al., (2009) identified that children enrolled in Medicaid had higher rates
of blood lead levels than children with private insurance. Rates of screening for children
enrolled in Medicaid vary from state to state. In 2015 the National Committee for
Quality Assurance (NCQA) reported that, nationally, just 66.5% of children enrolled in
Medicaid were screened for elevated blood lead levels despite the universal requirement
for these children to have screenings at both 1 and 2-years-of-age. A study of a Medicaid
cohort in Minnesota found that 65% of eligible children were screened for blood lead
levels. There was a further problem identified, in that required repeat screens did not
comply with regulations in 49.8% of cases (Knighton, Payne, & Speedie, 2016).
The combination of new lower levels of acceptable blood lead levels and poor
screening rates of at-risk children is problematic. A needs assessment performed at a
private pediatric practice in Harrisonburg, Virginia identified that despite Virginia Health
Department requirements, 2-year-old children enrolled in Medicaid were not receiving
any blood lead screening.
A Review of the Literature
A review of the literature was undertaken to determine effective methods for
increasing rates of blood lead level screening in children under 5 years of age.
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Methods for the Literature Review
A search for articles was conducted using CINAHL, PubMED and Ovid
databases. Search terms used were: “lead toxicity” and “lead screening”. These terms
were also combined with “intervention” and “child”. The search was restricted to
English language, and peer reviewed articles. The search included articles between 2000
and 2016, to include studies prior to the change in screening guidelines in 2012. This
wide range of years attempts to capture a larger number of studies specific to improving
rates of blood lead screening.
Articles were read and analyzed to identify if interventions were implemented to
increase blood lead level screening efforts. A challenge faced during the search was that
“lead” is a homograph with three meanings significant to health care. All searches
required careful screening to eliminate unrelated articles.
Thirty-five articles were selected for closer examination. Studies were excluded
if they primarily addressed ways to decrease lead levels in children or causes of elevated
lead. Studies were also excluded if their intent was to identify specific geographical
areas with high incidence of elevated blood lead levels, or to correlate elevated blood
lead levels with cognitive disorders. Ultimately, thirteen articles were selected for review.
Five of the articles studied rates of screening in multiple areas of pediatric health
promotion, including screening rates for anemia, tuberculosis, and obesity in addition to
rates of blood lead level screening (Bordley, Margolis, Stuart, Lannon & Keyes, 2001),
(Merepol et al., 2014), (Samaan, Brown, Morehous, Perkins, Kahn, & Mansour, 2016),
(Shaw, Wasserman, Barry, Delaney, Duncan, Davis & Berry, 2006), (Fairbrother,
Friedman, Butts, Cukor & Tassi, 2000). Merepol et al., (2014) provided the only
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randomized controlled trial. Five were before and after designs that were nonexperimental (Bordley et al., 2001); (Boreland, Lyle, Brown, & Perkins, 2015);
(Dowling, Miranda & Galaviz, 2008); (Samaan et al., 2016); (Shaw et al., 2006). Four of
the studies were cross-sectional analyses of data (Gioia, 2001); (Kaufmann, Clouse,
Olson, & Matte, 2000); (Leafe et al., 2015); (Vivier, Hogan, Simon, Leddy, Dansereau, &
Alario, 2001); and one was a qualitative analysis (Thomas, Boreland & Lyle, 2012). One
study was an expert opinion analysis (Fairbrother et al., 2000). One was an instrument
development study (Burns et al., 2012). All but two of the studies were conducted in the
United States.
Results of the Literature Review
Before implementation of any intervention to increase screening rates, the best
method to detect elevated blood lead levels needs to be determined. Burns et al. (2012)
found that screening questionnaires presented to parents were not effective in identifying
children with elevated blood lead levels, illustrating the importance of the blood lead
screen. The new CDC 2012 guidelines lowering the lead threshold of concern has the
potential to increase numbers of children with elevated blood lead levels that are
identified by a blood lead screen. Leafe et al. (2015) found an increase of prevalence of
lead elevation from 1% to 9.1% in a Philadelphia, PA neighborhood when new guidelines
were instituted. Detectable blood lead continues to be an issue for children in the United
States, making robust screening rates an important focus.
Gioia et al. (2001) found that children with health insurance were 42.6 times more
likely to have a blood lead level checked than children without insurance. Among
children with insurance, those enrolled in Medicaid were less likely to have a blood lead
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level checked, yet children enrolled in Medicaid insurance are more likely to have
elevated blood lead. Data analyzed from the Third National Health and Nutrition
Examination Survey demonstrated that 12.8% of children enrolled in Medicaid had lead
levels above 10 ug/dL, while 3.7% of non-Medicaid enrolled children had the same

elevations. Children enrolled in Medicaid made up 30% of the NHANES study yet were
responsible for 60% of the elevated blood lead levels (Kaufman et al., 2000).
Quality monitoring for Medicaid includes reporting screenings and routine care.
Lead screenings are part of the data sets reported to Medicaid (Fairbrother et al., 2000).
In their work, Fairbrother et al. (2000) found that providers did not believe that this
monitoring was effective at increasing rates of screening. The literature review however,
identified several common themes that showed improvement in lead screening rates with
the use of office-based initiatives.
Systems-based approaches can be effective, specifically office-based initiatives
that address provider and staff knowledge, process improvement, and access for patients.
Boreland et al. (2015) showed an increase in the proportion of children screened from
0.39 to 0.60 (95% CI [0.12-0.29]) by implementing a point of care lead screening test in
their clinic, increasing access for their families. Samaan et al. (2016) introduced a
preventive care service bundle which included lead screening, and preventive care
screenings increased from 58% of children to 92%. Bordley et al. (2001) increased
screenings in eight primary care offices by having each office develop a tailored system
to improve delivery of preventive care services.
increased from 12% to 48%.

Age appropriate lead screenings
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A second theme that emerged was the use of a facilitator to implement efforts to
increase screening. Samaan et al. (2016) had personnel dedicated to assisting providers
and staff as they implemented and ordered their new service bundles. Meropol et al.
(2014) conducted a randomized controlled trial where practice based pediatric preventive
care improvement techniques were implemented under the direction of a facilitator
dedicated to the process. This facilitator was hired to support the process and had no
other clinic responsibilities other than tracking the preventive services. All areas of
preventive services, including lead screenings, saw improvements with this process.
Finally, rapid feedback was noted in four of the office-based studies. Frequent
evaluations with timely reporting to providers and staff proved beneficial in each study.
Bordley et al. (2001), provided sessions for their care teams where chart review
information was relayed back to them at various points during the study. Meropol et al.
(2014) had their facilitators visit sites weekly with sample chart reviews. Samaan et al.
(2016) had data managers pull information from the electronic health record to create
evaluative reports for providers. A statewide initiative in Vermont increased lead
screening rates from 72% to 85% with practice driven interventions. Feedback was
provided by collaborative phone calls, and monthly reports to track adherence to clinic
protocols (Shaw et al., 2006).
Provider and patient knowledge were also found to play a role in rates of blood
lead testing. Vivier et al. (2001) found lead testing rates in Rhode Island for children
enrolled in Medicaid reached 80%, considerably higher than national rates. Rhode Island
was known for having a problem with elevated blood lead levels in children, and the state
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has extensive educational programs for both providers and citizens, as well as a managed
care coordinator for the children enrolled in Medicaid (Vivier et al., 2001).
Thomas et al. (2012) conducted studies in New South Wales, Australia to
determine why blood lead testing rates were low, and themes that emerged in the
interview process included a lack of perceived health risks related to lead, as well as
socio-economic factors making blood lead screening access difficult. Similar work by
Dowling et al. (2008) in San Diego found that families were unfamiliar with the risks of
elevated blood lead levels and were unaware that it was recommended. Other reasons for
missed tests included lack of transportation and misunderstanding regarding the blood
draw process.
In summary, risk for elevated blood lead remains. Rates of blood lead screening
in children are low, particularly with Medicaid children., however, office-based
interventions show promise to increase blood lead screening.
Aim
The aim of this project is that by April 1, 2018 we will improve the rate of blood
lead screening of children enrolled in Medicaid at their 2-year-old well child check to
90%. This project will take place at a private pediatric practice in the Shenandoah Valley
of Virginia. The expectation is that this project will increase the understanding of the
guidelines for screening children enrolled in Medicaid for blood lead levels. This more
complete understanding and implementation of techniques to increase rates of screening
will capture children with risk factors who have elevated lead levels, allowing for
remediation to occur. It will also improve adherence to Medicaid requirements for blood
lead screening. The process will also introduce this pediatric practice to quality
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improvement techniques, allowing the office to meet future clinical practice improvement
goals.
Rationale
Increasing blood lead level screening adherence demands a change in practice,
and an increased awareness of screening requirements. Improvement was accomplished
by utilizing the Institute for Healthcare Improvement’s (IHI) Model for Improvement
(Institute for Healthcare Improvement, 2017). The model asks three questions to guide
the project. What does the project want to accomplish? How will you know you have
accomplished your goals? and What change can be made to accomplish your goals? This
model requires a thorough needs assessment. There is also a mechanism to study
whether unintended consequences occur following the interventions. These are referred
to as balancing measures. The IHI model then provides the platform for continuous
evaluation and facilitation by using PDSA cycles. Success is defined by studying the
process measures, or, the way the data is manipulated. This framework matched the needs
of this quality improvement project, as it addresses change in a rapid format with
continuous feedback.
Methods
Context and Stakeholders
The clinic is a privately-owned pediatric office in the Shenandoah Valley in
Virginia. Currently, approximately 60% of the clinic’s children are enrolled in Medicaid.
The clinic employs four pediatricians and two nurse practitioners to provide a medical
home for children from birth, to transition to adult medicine. Prior to the quality
improvement project the clinic screened for blood lead elevation in every 1-year-old
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child. There was widespread acceptance of this screening from nursing staff, providers,
and parents, but they had not yet adopted the Medicaid requirement to perform a second
screen in the 2-year-old. De-identified data from children between ages 1 and 3 were
studied to ascertain precise rates of blood lead screening and the effect of an intervention
to improve rates of screening.
Input was required from the practice manager, the provider group, and the RN’s,
specifically the Nurse Manager. The pediatricians and nurse practitioners also needed to
be on board with the improvement. The children and their parents were also
stakeholders. The RNs and providers had high power and high interest in this project and
needed to be engaged.
Interventions
The proposal was approved by the James Madison University (JMU)
Investigational Review Board. Before the initiation of the PDSA cycles a needs
assessment was performed. The IHI Model for Improvement uses an Ishikawa diagram
to study the environment and stakeholders (Appendix 1, Figure 1). A data collection tool
was used for a retrospective chart audit of 1 and 2-year-olds who have been seen in clinic
over the past year for a well child check. Children 1 and 2 years of age, enrolled in
Medicaid, who had a well child check at the clinic during 2017 were included. Once
these charts were identified, systematic sampling was used and every third record was
chosen to review, which resulted in forty-three charts of 1-year-old children enrolled in
Medicaid and thirty-five charts of 2-year-old children enrolled in Medicaid. The data
collected was de-identified and included age, sex, number and date of lead screenings
performed, and the number of elevated blood lead levels.
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The first intervention was an in-service of all staff reviewing the current
guidelines, and a posting of new laminated guidelines at weigh station and lead collection
station. The rationale for this intervention was that the clinic mission statement is to be
the premier pediatric provider in the area, and the staff will be motivated to follow most
recent guidelines. Materials for this intervention were laminated lead screening
guidelines and an in-service to discuss the new process with the entire staff. The staff
were then to deliver the change by screening 2-year-old children at their well child
checks. This was the first PDSA cycle and it was to run for three weeks. Necessary
changes were made as issues occurred. Run charts were maintained, with data pulled two
times a week.
Cycle two was planned to test the results of the additional implementation of an
electronic health record flag in the charts of eligible 1 and 2-year-old children. Every
child between 1 and 3-years-of-age was to have a reminder flag indicating the need for
blood lead level screening. Bordley, Margolis, Stuart, Lannon, & Keyes, (2001)
ascertained that reminders such as flags on charts can increase screening rates. Lead
screening rates in their study increased from 12% to 48% with the use of reminders
tailored to the individual offices’ needs (Bordley et al., 2001). The practice manager
activated these flags. In the results, it is noted that this became the third PDSA cycle.
Cycle three initially was to implement an intervention with one provider and
nurse team initiating a morning huddle to review the day’s patients and identify children
in need of a blood lead screen. Meropol et al., (2014) showed an increase in testing rates
after implementation of a huddle process. This cycle never occurred, again see the results
section for details.
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Study of the Intervention
A brief chart review was completed 9/7/17, to determine blood lead level screening
practices. Interviews with staff were conducted to establish knowledge regarding
Medicaid screening requirements, and to complete the Ishikawa cause and effect
diagram. During this process it was discovered that this clinic does not screen 2-year-old
children enrolled in Medicaid for blood lead levels, despite Medicaid requirements to
screen children at age 1 and 2-years-of-age. A physical review of work areas and posted
guidelines was completed, identifying where guidelines were posted, and whether they
were up to date. No physical reminders to collect blood lead levels were found, and
posted guidelines were outdated.
Once the PDSA cycles were underway run charts were utilized to study whether the
planned interventions were effective. Data points were collected two times a week and
plotted against the baseline rate of blood lead screening, and the goal of blood lead
screening. There were two concurrent run charts: one for the rate of 2-year-old children
tested, and one for the rate of 1-year-old children tested. The total number of children
seen each day in clinic was tracked throughout the study.
Measures
Outcome measures
The outcome measure was to increase from baseline, the percentage of 2-year-old
children enrolled in Medicaid receiving a blood lead screening at their 2-year well child
check. A run chart tracked this percentage. The numerator was the number of 2-year-old
children enrolled in Medicaid screened at their well child check, and the denominator was
the number of 2-year-old children enrolled in Medicaid attending their well child visits.
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Process measures
The first process measure was to identify the number of 2-year old children
enrolled in Medicaid who presented for a 2-year well child check each week. This was
collected each Tuesday and Friday during project implementation.
The second process measure was to identify the number of 2-year old children
enrolled in Medicaid who had a blood lead screening completed at their 2-year well child
check each week. This was collected each Tuesday and Friday during project
implementation.
Statistical Analysis
Rates of 1 and 2-year-old children screened from cycle one to cycle two of the
PDSA intervention were compared with a Fisher’s Exact test to determine whether the
intervention had effect on the rates of screening. This test was repeated with the rates of
1 and 2-year-old children screened from cycle two to cycle three of the PDSA
interventions. The total number of children seen during each PDSA cycle were compared
with a one-way ANOVA to ensure that there was not a wide variation in the busyness of
the clinic between the cycles.
Balancing Measures
Several measures were tracked to measure unexpected effects on other areas of
the clinic. First, the percentage of 1-year-olds with lead screenings completed was
tracked to ensure that focus on the 2-year-old did not decrease the already robust 1-yearold screening rates. The number of 1-year-old children enrolled in Medicaid attending
their 1-year-old well child check and having a blood lead screen was the numerator, and
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the number of 1-year-old children enrolled in Medicaid insurance attending their 1-year
well child check was the denominator.
The total number of children seen in clinic each week was also determined to
understand the effect of clinic volume on children screened for blood lead levels.
Results

Use of the IHI Model for Improvement and PDSA cycles allowed for continuous
feedback and adjustment to the intervention cycle. The first intervention, the educational
session, not only did not produce any increase in screening rates of 2-year-old children
enrolled in Medicaid, but also decreased the screening rate of all 1-year-old children
enrolled in Medicaid. After the educational intervention, nurses were dismayed that they
were not meeting the Medicaid requirements. However, they hesitated to implement a
new screening practice without a written policy from the medical director. Obtaining,
verifying and posting this new policy became the second cycle of the PDSA interventions
(see Appendix 2, Table 1).
Run charts of the balancing measure to ensure no unintended consequences
occurred revealed that 100% of 1-year-old children enrolled in Medicaid were being
screened until the educational intervention. After that intervention, the rate dropped to a
low of 66%. The nurses were confused about the place of the new screening of the 2year-olds and became confused about their current practice. Once the policy was signed
and in place, the screening rate of 1-year-old children enrolled in Medicaid returned to
100% and remained there for the duration of the project (Appendix 3, Figure 2.)
A Fisher’s Exact Test was used to determine the statistical significance of the
change in the rates of screening between cycle one and two, and cycle two and three.
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There proved to be a statistically significant difference between the rates of screening
from PDSA cycle 1 (the educational intervention and PDSA cycle 2 (the policy change).
The 1-sided p-value was <0.001. The significance of the difference in PDSA cycle 2 (the
policy change) to PDSA cycle 3 (the EHR flag) was less dramatic, with a 1-sided p-value
of <0.040. These results are consistent with the run charts.
As a balancing measure an ANOVA test was run on the total numbers of patients
seen in clinic each day, during each PDSA cycle. There was no statistically significant
difference in the numbers seen in clinic in each PDSA cycle (P <0.296), indicating that
the null hypothesis cannot be rejected.
The aim of the project was to increase screening of 2-year-old children enrolled in
Medicaid. While the needs assessment revealed a screening rate of 0, the first week of
data collection prior to the educational intervention (PDSA cycle 1) showed a screening
rate of 25%. After the educational intervention, the screening rate dropped to zero once
again. Upon the implementation of the policy change (PDSA cycle 2) the rate of
screening for 2-year-old children enrolled in Medicaid increased to 100% but remained
there just two weeks. Five weeks after the policy change the screening rate of 2-year-old
children enrolled in Medicaid dropped to 33%. At this time the addition of an EHR flag
was implemented (PDSA cycle 3). This increased the screening rate of 2-year-old
children enrolled in Medicaid to 50% in the first week, but it was determined that the flag
was not functioning properly. The flag was fixed, and the screening rate for 2-year-old
children enrolled in Medicaid increased to 100% and remained there for the final five
weeks of the project. See Appendix 3, Figure 3.
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Discussion

While the educational intervention was necessary to this project, the results show
that in and of itself, education is not enough. It was surprising how effective the simple
act of implementing a written policy signed by the physician proved to be. However, the
effect of this policy implementation showed signs of not persisting. The final cycle of the
added EHR flag cemented the change. PDSA cycles in this project were only effective
with the constant feedback and facilitation by the study team.
Facilitators and Barriers
The final success of this project was dependent on the dedicated staff at at the
clinic. The project was consistent with its organizational mission, and the values of the
nurses and providers. The practice manager was on board with the project and provided
an important role as facilitator and bridge between the staff, providers and study team.
Without they buy-in from the practice manager, the adjustments to the PDSA cycle
requiring a written policy change would not have been possible. The relationship of the
investigator to the practice manager was key.
While the staff were the reason for the success, they were also one of the barriers.
As predicted, there was hesitancy from a handful of the nurses to simply adopt best
practice and work to the full scope of their license. The IHI framework allowed for
continual assessment of the environment, and adjustment to the PDSA cycle, which
resulted in the adoption of the new practice of screening the 2-year-olds enrolled in
Medicaid. While the hope was that the all RN staff would adjust their screening practice
with the educational intervention, the reality of the clinic environment showed that
education alone was not enough.
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An unintended but not unexpected occurrence during the PDSA cycle
implementation was the initial drop in the robust rate of 1-year-old lead screening.

Fortunately, the project design anticipated this and provided for careful tracking of these
screenings as the 2-year-old screenings were addressed. Close work with the practice
manager resulted in a quick course correction. Again, the PDSA rapid feedback was
crucial to catch and address this issue.
Limitations
This project was carried out in a small, local practice. While the interventions are
evidence based, implementation in a variety and larger number of clinics would be
necessary to determine if the results are replicable. My proposed chi-squared statistical
analysis needed to be modified to a Fisher’s Exact test due to small numbers. These
small numbers were due, in part, to an extremely virulent flu season which necessitated
the cancelling of well child check appointments to accommodate the influx of ill children
at the clinic.
Conclusion
National trends show that children with increased risk of lead exposure are not
appropriately screened. Environmental improvements have made a significant impact on
the levels of lead in paint, gasoline and water pipes, however, children continue to
experience new lead exposures. This fact highlights the importance of robust screenings
for blood lead levels in children known to have high risk of exposure, such as those
enrolled in Medicaid.
The IHI model is an evidence-based method to change practice and behavior and
proved to be an effective method to increase screening in one private pediatric clinic.
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The results of this project proved to be consistent with the literature as noted in the
literature search, and the IHI model produced lasting results and could be used for many
office-based practice improvements.
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Appendix 1

Figure 1 Ishikawa Diagram
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Appendix 2

Table 1 PDSA Cycles
Planned PDSA cycles
1.

An educational lunch and learn
was held to increase staff
knowledge on appropriate lead
testing.
2. An EHR flag was to be
implemented to capture all
children requiring lead screening.
3.

A morning huddle to increase
communication between nurses
and providers was to be held each
morning before clinic.

Actual PDSA cycles
1.

An educational lunch and learn
was held to increase staff
knowledge on appropriate lead
testing.
2. Fallout from the educational
session necessitated a formal
written and signed policy change
to be put into place.
3. The EHR flag was put into effect
and brought screening rates to
100%, no further cycles were
implemented.
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Appendix 3

Figure 2, Balancing Measure Run Chart
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Figure 3, Outcome Measures Run Chart
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